Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Applied Therapeutics, Inc. Director's Dealing 2025

Mar 27, 2025

34263_dirs_2025-03-26_685df0a5-a178-4101-a12e-ad00bcc22a4f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Applied Therapeutics, Inc. (APLT)
CIK: 0001697532
Period of Report: 2025-03-24

Reporting Person: Funtleyder Leslie D. (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-03-24 Common Stock A 350000 Acquired 740459 Direct

Footnotes

F1: Consists of compensatory Restricted Stock Units ("RSUs") granted under the Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory RSU represents a contingent right to receive one share of the Issuer's common stock. One fourth (1/4th) of the compensatory RSUs shall vest on March 24, 2026, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory RSUs shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.